Every record from Janoshik · page 41
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-019982 | Semaglutide | ERP | ERP-2508-S6110 | 2025-Q3 | 99.29 | 3.46 | 93.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019758 | Semaglutide | HJ | HJ-2507-Y3362 | 2025-Q3 | 99.20 | 3.04 | 105.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021270 | Pemvidutide | BCH | BCH-2506-G6608 | 2025-Q3 | 97.56 | 5.97 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020196 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2507-S1153 | 2025-Q3 | 99.93 | 5.57 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019949 | 5-Amino-1MQ | SWB | SWB-2507-E6159 | 2025-Q3 | 99.14 | 6.16 | 91.0 | Supplier-supplied | 1 | FAIL |
| AX-2025-019754 | Semaglutide | HJ | HJ-2507-Y3362 | 2025-Q3 | 98.45 | 3.28 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018944 | NAD+ | FGP | FGP-2502-E1024 | 2025-Q3 | 99.07 | 11.27 | — | Laboratory-retained | 0 | FAIL |
| AX-2025-018864 | Desmopressin | QSC | QSC-2505-N8999 | 2025-Q3 | 99.61 | 4.56 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-018797 | AOD-9604 | QSC | QSC-2508-B8479 | 2025-Q3 | 99.33 | 3.48 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018496 | MOTS-c | WWB | WWB-2505-G2801 | 2025-Q3 | 99.36 | 2.95 | 100.2 | Supplier-supplied | 0 | PASS |
| AX-2025-021247 | L-Glutathione (reduced) | BCH | BCH-2508-X6429 | 2025-Q3 | 97.71 | 6.50 | 100.8 | Supplier-supplied | 0 | FAIL |
| AX-2025-020194 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2507-S1153 | 2025-Q3 | 99.93 | 5.30 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019809 | Semaglutide | HJ | HJ-2507-P3933 | 2025-Q3 | 98.89 | 3.42 | 101.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020667 | PT-141 (Bremelanotide) | SSA | SSA-2507-Y8342 | 2025-Q3 | 98.37 | 4.39 | 102.8 | Buyer-sourced | 0 | FAIL |
| AX-2025-020801 | PT-141 (Bremelanotide) | SGN | SGN-2505-A9617 | 2025-Q3 | 98.20 | 3.91 | 102.2 | Supplier-supplied | 1 | FAIL |
| AX-2025-020767 | Semaglutide | SGN | SGN-2502-F9601 | 2025-Q3 | 98.27 | 5.29 | 105.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020758 | BPC-157 | SGN | SGN-2507-F9952 | 2025-Q3 | 98.83 | 4.31 | 96.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020072 | Retatrutide | ERP | ERP-2507-P8449 | 2025-Q3 | 97.94 | 1.80 | 104.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019561 | Semaglutide | Homopeptide | HOMO-2506-M1846 | 2025-Q3 | 98.82 | 6.24 | 92.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019038 | BPC-157 | JEEP | JEEP-2506-R3035 | 2025-Q3 | 98.96 | 3.23 | 105.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018698 | Retatrutide | QSC | QSC-2502-D6580 | 2025-Q3 | 97.54 | 6.85 | 100.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021265 | Pemvidutide | BCH | BCH-2506-G6608 | 2025-Q3 | 97.53 | 5.58 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020592 | Retatrutide | SSA | SSA-2508-N7223 | 2025-Q3 | 97.49 | 3.36 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019192 | Tirzepatide | TFC | TFC-2507-T5380 | 2025-Q3 | 97.57 | 3.57 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-018986 | KPV | FGP | FGP-2506-L1816 | 2025-Q3 | 99.71 | 4.94 | 101.0 | Supplier-supplied | 1 | FAIL |
| AX-2025-021312 | GHRP-2 | BCH | BCH-2506-L7534 | 2025-Q3 | 98.04 | 8.61 | 103.4 | Supplier-supplied | 2 | FAIL |
| AX-2025-021310 | GHRP-2 | BCH | BCH-2506-L7534 | 2025-Q3 | 98.69 | 8.49 | 95.5 | Supplier-supplied | 3 | FAIL |
| AX-2025-020699 | Semaglutide | GL Biochem | GLBI-2502-B8344 | 2025-Q3 | 97.39 | 6.18 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020435 | GHRP-6 | KP | KP-2503-L4599 | 2025-Q3 | 98.08 | 3.76 | 89.8 | Buyer-sourced | 3 | FAIL |
| AX-2025-019988 | Semaglutide | ERP | ERP-2508-S6110 | 2025-Q3 | 99.27 | 3.27 | 98.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019806 | Semaglutide | HJ | HJ-2507-P3933 | 2025-Q3 | 99.78 | 4.49 | 98.4 | Supplier-supplied | 0 | PASS |
| AX-2025-019141 | PEG-MGF | TFC | TFC-2507-M4201 | 2025-Q3 | 98.02 | 3.75 | 95.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019108 | BPC-157 | JEEP | JEEP-2507-V4206 | 2025-Q3 | 99.28 | 4.62 | — | Supplier-supplied | 3 | FAIL |
| AX-2025-018725 | MK-677 (Ibutamoren mesylate) | QSC | QSC-2507-F6894 | 2025-Q3 | 99.78 | 5.24 | 92.3 | Supplier-supplied | 2 | FAIL |
| AX-2025-018617 | Pemvidutide | QYB | QYB-2502-V5083 | 2025-Q3 | 99.01 | 3.77 | 94.5 | Supplier-supplied | 4 | FAIL |
| AX-2025-020959 | CJC-1295 (no DAC) | CPC | CPC-2503-R2710 | 2025-Q3 | 97.01 | 5.63 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-020935 | PT-141 (Bremelanotide) | CPC | CPC-2502-X3345 | 2025-Q3 | 98.61 | 4.66 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020837 | Melanotan II | SGN | SGN-2508-U1379 | 2025-Q3 | 98.36 | 4.53 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020690 | Semaglutide | GL Biochem | GLBI-2505-V8283 | 2025-Q3 | 97.38 | 4.22 | 98.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018998 | PT-141 (Bremelanotide) | FGP | FGP-2508-L2918 | 2025-Q3 | 99.93 | 4.58 | 102.8 | Supplier-supplied | 0 | PASS |